Paid Clinical Trials Augusta

Discover 230 paid clinical trials in Augusta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 230

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Augusta GA, Columbia SC, Anderson SC, Union SCshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Augusta GA, Union SC, Spartanburg SC, Greer SCshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Compliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical PatientsCompliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients

Recruiting

Sponsor:

Augusta University

Location:

Augusta GA

Code:

NCT03968666

Conditions

Surgery

Anesthesia

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Augusta GA, Greenville SC, Easley SC, Seneca SCshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyImproving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Recruiting

PHASE2

Sponsor:

Seattle Institute for Biomedical and Clinical Research

Location:

Augusta GA, Boston MA, Seattle WA

Code:

NCT04301765

Conditions

Hypogonadism, Male

Cancer

Fatigue

Eligibility Criteria

Sex: Male

Age: 55+

Healthy Volunteers: Not accepted

Interventions

testosterone 1.62% gel

placebo gel

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid TumorsA Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Recruiting

PHASE1

Sponsor:

Chugai Pharmaceutical

Location:

Augusta GA, Charleston SC, Nashville TN, Houston TXshow 1 more

Code:

NCT05735366

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SAIL66

Obinutuzumab

Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive SacrocolpopexySingle-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Augusta GA, Winston-Salem NC, Coconut Creek FL, Chicago ILshow 1 more

Code:

NCT04586166

Conditions

Stress Urinary Incontinence

Pelvic Floor Disorders

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

RP Sling

SIS

Effects of Xal-Ease on Patient Compliance With XalatanEffects of Xal-Ease on Patient Compliance With Xalatan

Recruiting

Sponsor:

Augusta University

Location:

Augusta GA

Code:

NCT00573638

Conditions

Glaucoma

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Xal-Ease device to be used with Xalatan eye drops

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.

Recruiting

PHASE2

PHASE3

Sponsor:

argenx

Location:

Augusta GA, Summerville SC, Atlanta GA, Jacksonville FLshow 50 more

Code:

NCT05523167

Conditions

Active Idiopathic Inflammatory Myopathy

Myositis

Dermatomyositis

Polymyositis

Immune-Mediated Necrotizing Myopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EFG PH20 SC

PBO

Project: Every Child for Younger Patients With CancerProject: Every Child for Younger Patients With Cancer

Recruiting

Sponsor:

Children's Oncology Group

Location:

Augusta GA, Columbia SC, Greenville SC, Macon GAshow 172 more

Code:

NCT02402244

Conditions

Adrenal Gland Pheochromocytoma

Carcinoma In Situ

Central Nervous System Neoplasm

Childhood Immature Teratoma

Childhood Langerhans Cell Histiocytosis

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Medical Chart Review